摘要
报告介绍了2013年第4季度各国获得简化新药申请(ANDA)批准、《药品管理档案》(DMF)申报、遭遇专利挑战的情况,以及生物仿制药市场、仿制药行业交易和相关仿制药企业的进展。
This article provides a comprehensive overview of ANDAs and DMFs by country of origin of applicant during the first quarter of 2013, and groups with the most patent challenges. This includes covers markets and deals of biosimilars, these generics manufacturers are also discussed.
出处
《药学进展》
CAS
2014年第8期615-620,共6页
Progress in Pharmaceutical Sciences
